Brief: Wilex adopts capital measures

Heidelberg Pharma AG

23/11/2015 10:11

Nov 23 (Reuters) - Wilex AG  WL6G.DE : 
    * Unveils financing strategy for further development of ADC 
Technology and adopts capital measures 
    * Main shareholder Dievini Hopp Biotech Holding GmbH & Co. 
KG is prepared to invest at least 10 million euros ($10.62 
million) if subscription price does not exceed 1.84 euros per 
share 
    * To safeguard short-term financing to implement two rights 
issues using authorised capital without publishing a prospectus 
    * These are expected to generate gross issue proceeds of up 
to 2.5 million euros for company 
    * Is planning to increase company's share capital by around 
10 pct,  by issuing 930,560 new no par value bearer shares; 
issue price per share is 1.84 euros per share 
    * In addition is planning to increase share capital by 
issuing up to 443,124 new shares at a subscription price of 1.84 
euros per share, offered to shareholders for subscription at a 
21:1 ratio 
    * Expects to generate issue proceeds of up to 815,348.00 
euros from this transaction 
 
Source text for Eikon:  ID:nEQ6JwDfga  
Further company coverage:  WL6G.DE  
 
($1 = 0.9414 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))